Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
DUBLIN, IRELAND, May 01, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the following conference in May:
UBS Global Healthcare Conference
- Date: May 22, 2018
- Presentation Time: 9:30 a.m. ET
- Location: New York
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
| Contacts: | |
| Investors: Tina Ventura Senior Vice President, Investor Relations [email protected] | U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer [email protected] |
| Ruth Venning Executive Director, Investor Relations [email protected] | Ireland Media: Ray Gordon Gordon MRM [email protected] |
